Correction: FOXC1 promotes melanoma by activating MST1R/PI3K/AKT pathway and is associated with poor prognosis in melanoma.
Publication Title
Oncotarget
Document Type
Article
Publication Date
6-13-2024
Keywords
california; sjci; santa monica
Clinical Institute
Cancer
Specialty/Research Institute
Dermatology
Specialty/Research Institute
Endocrinology
Specialty/Research Institute
Oncology
DOI
10.18632/oncotarget.28590
COinS